1 Akcea Therapeutics Inc Receivables Turnover Ratio (AKCA), from the second quarter 2020 to the second quarter 2019 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Akcea Therapeutics Inc   (NASDAQ: AKCA)
 

Akcea Therapeutics Inc Accounts Receivables Turnover Ratio from the second quarter 2020 to the second quarter 2019

Quarterly Results, Trends, Rankings, Statistics


Akcea Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2020 to a ratio of 213.35, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2020. Average receivable collection period, for the Akcea Therapeutics Inc in Jun 30 2020 quarter, has decreased to 2 days, compared to 4 days, in the Mar 31 2020 quarter.

If we take a look into Healthcare sector Akcea Therapeutics Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Akcea Therapeutics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKCA Receivables Turnover Ratio (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Receivable Change - -66.25 % - - -
Y / Y Revenue Change -15.95 % -90.19 % 2621.19 % 7.19 % 45.31 %
Receivable Turnover Ratio (TTM) 213.35 95.86 102.88 56.14 58.18
AKCA's Total Ranking # # # # #
Accounts Receivable average collection period days 2 4 4 7 6
Seq. Receivable Change - -24.73 % 399.38 % -91.82 % 9.78 %
Seq. Revenue Change 39.21 % -94.21 % 1245.42 % -22.53 % -83.75 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





AKCA Company Profile • Back to AKCA Efficiency Comparisons • Compare AKCA Receivables Turnover Ratio to its Competitors

Financial Statements
Akcea Therapeutics Inc 's Accounts Receivable $ 0 Millions Visit AKCA's Balance sheet
Akcea Therapeutics Inc 's Sales TTM $ 337 Millions Visit AKCA's Income Statement
Sources of AKCA's Revenues Visit AKCA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AKCA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AKCA's Growth Rates AKCA's Roa AKCA's Inventory Turnover Ratio AKCA's Dividend Comparisons
AKCA's Profitability Ratios AKCA's Roi AKCA's Asset Turnover Ratio AKCA's Dividend Growth
AKCA's Valuation Ratios AKCA's Roe AKCA's Financial Strength Ratios AKCA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2020, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2020 Receivable at quarter ending Jun 30 2020

Date modified: 2026-08-29T17:40:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.